{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T22:29:25Z","timestamp":1791066565115,"version":"4.1.0"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["neurology.org"],"crossmark-restriction":true},"short-container-title":["Neurology"],"published-print":{"date-parts":[[1996,8]]},"DOI":"10.1212\/wnl.47.2.444","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T13:22:30Z","timestamp":1336915350000},"page":"444-448","update-policy":"https:\/\/doi.org\/10.1212\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":94,"title":["Apolipoprotein E genotype does not influence rates of cognitive decline in Alzheimer's disease"],"prefix":"10.1212","volume":"47","author":[{"given":"J. H.","family":"Growdon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. J.","family":"Locascio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Corkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Gomez-Isla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. T.","family":"Hyman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","first-page":"6","volume":"240","year":"1988","unstructured":"Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1988;240:622-630.","journal-title":"Science"},{"key":"e_1_3_1_3_2","first-page":"3","volume":"28","year":"1987","unstructured":"Ordovas JM, Litwack-Klein L, Wilson PWF, Schaefer MM, Schaefer EJ. Apolipoprotein E isoform phenotyping methodology and population frequency with identification of apoE1 and apoE5 isoforms. J Lipid Res 1987;28:371-380.","journal-title":"J Lipid Res"},{"key":"e_1_3_1_4_2","first-page":"1","volume":"43","year":"1993","unstructured":"Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993;43:1467-1472.","journal-title":"Neurology"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)91878-P"},{"key":"e_1_3_1_6_2","first-page":"5","volume":"11","year":"1993","unstructured":"Rebeck GW, Reiter JS, Strickland DK, Hyman BT. Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron 1993;11:575-580.","journal-title":"Neuron"},{"key":"e_1_3_1_7_2","first-page":"6","volume":"54","year":"1994","unstructured":"Tsai M-S, Tangalos EG, Petersen RC, et al. Apoliproprotein E: risk factor for Alzheimer's disease. Am J Hum Genet 1994;54:643-649.","journal-title":"Am J Hum Genet"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.261.5117.9"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng0594-1"},{"key":"e_1_3_1_10_2","first-page":"4","volume":"175","year":"1994","unstructured":"West HL, Rebeck GW, Hyman BT. Frequency of the apolipoprotein E epsilon 2 allele is diminished in sporadic Alzheimer disease. Neurosci Lett 1994;175:46-48.","journal-title":"Neurosci Lett"},{"key":"e_1_3_1_11_2","first-page":"6","volume":"37","year":"1995","unstructured":"van Duijn CM, de Knijff P, Wehnert A, et al. The apolipoprotein E epsilon 2 allele is associated with an increased risk of early-onset Alzheimer's disease and a reduced survival. Ann Neurol 1995;37:605-610.","journal-title":"Ann Neurol"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410390104"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.1.1"},{"key":"e_1_3_1_14_2","first-page":"9","volume":"34","year":"1984","unstructured":"McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.","journal-title":"Neurology"},{"key":"e_1_3_1_15_2","first-page":"1","volume":"52","year":"1995","unstructured":"Locascio J, Growdon JH, Corkin S. Cognitive test performance in detecting, staging, and tracking Alzheimer's disease. Arch Neurol 1995;52:1087-1099.","journal-title":"Arch Neurol"},{"key":"e_1_3_1_16_2","first-page":"7","volume":"114","year":"1968","unstructured":"Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry 1968;114:797-811.","journal-title":"Br J Psychiatry"},{"key":"e_1_3_1_17_2","first-page":"3","volume":"1","year":"1986","unstructured":"Weintraub S. The record of independent living: an informant-completed measure of activities of daily living and behavior in elderly patients with cognitive impairment. Am J Alzheimer Care 1986;1:35-39.","journal-title":"Am J Alzheimer Care"},{"key":"e_1_3_1_18_2","first-page":"4","volume":"47","year":"1996","unstructured":"Kurz A, Egensperger R, Haupt M, et al. Apolipoprotein E allele epsilon 4, cognitive decline, and deterioration of everyday performance in Alzheimer's disease. Neurology 1996;47:440-443.","journal-title":"Neurology"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1080\/01688638008403776"},{"key":"e_1_3_1_20_2","unstructured":"Benton AL. The Revised Visual Retention Test. New York: Psychological Corporation 1974."},{"key":"e_1_3_1_21_2","unstructured":"Kaplan E Goodglass H Weintraub S. Boston Naming Test. Philadelphia: Lea & Febiger 1983."},{"key":"e_1_3_1_22_2","first-page":"6","volume":"18","year":"1935","unstructured":"Stroop JR. Studies of interference in serial verbal reactions. J Exp Psychol 1935;18:643-662.","journal-title":"J Exp Psychol"},{"key":"e_1_3_1_23_2","unstructured":"Golden CH Hammeke TA Purisch AD. Manual for the Luria-Nebraska Neuropsychological Battery. Los Angeles: Western Psychological Services 1980."},{"key":"e_1_3_1_24_2","unstructured":"Wechsler D. Wechsler Adult Intelligence Scale-Revised. New York: Psychological Corporation 1981."},{"key":"e_1_3_1_25_2","first-page":"4","volume":"29","year":"1991","unstructured":"Cronin-Golomb A, Corkin S, Rizzo JF, Cohen J, Growdon JH, Banks KS. Visual dysfunction in Alzheimer's disease: relation to normal aging. Ann Neurol 1991;29:41-52.","journal-title":"Ann Neurol"},{"key":"e_1_3_1_26_2","doi-asserted-by":"crossref","unstructured":"Cronin-Golomb A Sugiura R Corkin S Growdon JH. Incomplete achromatopsia in Alzheimer's disease. Neurobiol Aging 14:471-477 1993.","DOI":"10.1016\/0197-4580(93)90105-K"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0197-4580(94)90156-2"},{"key":"e_1_3_1_28_2","first-page":"1","volume":"1","year":"1991","unstructured":"Arnold SE, Hyman BT, Flory J, Damasio AD, Van Hoesen GW. The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cereb Cortex 1991;1:1-6.","journal-title":"Cereb Cortex"},{"key":"e_1_3_1_29_2","first-page":"4","volume":"245","year":"1989","unstructured":"Yankner BA, Dawes LR, Fisher S, Villa-Koomaroff L, Oster-Granite ML, Neve RL. Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. Science 1989;245:417-420.","journal-title":"Science"},{"key":"e_1_3_1_30_2","first-page":"4","volume":"92","year":"1995","unstructured":"Higgins LS, Rodems JM, Catalano R, Quon D, Cordell B. Early Alzheimer disease-like histopathology increases in frequency with age in mice transgenic for beta-APP751. Proc Natl Acad Sci USA 1995;92:4402-4406.","journal-title":"Proc Natl Acad Sci USA"},{"key":"e_1_3_1_31_2","first-page":"3","volume":"1","year":"1995","unstructured":"Smith MA, et al. Tau protein directly interacts with the amyloid beta-protein precursor: implications for Alzheimer's disease. Nature Med 1995;1:365-369.","journal-title":"Nature Med"},{"key":"e_1_3_1_32_2","first-page":"4","volume":"53","year":"1994","unstructured":"Selkoe DJ. Alzheimer's disease: a central role for amyloid. J Neuropathol Exp Neurol 1994;53:438-447.","journal-title":"J Neuropathol Exp Neurol"},{"key":"e_1_3_1_33_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.47.1_Suppl_1.6S"},{"key":"e_1_3_1_34_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410370104"},{"key":"e_1_3_1_35_2","first-page":"2","volume":"35","year":"1987","unstructured":"Huff FJ, Growdon JH, Corkin S, Rosen TJ. Age at onset and rate of progression of Alzheimer's disease. J Am Geriatric Soc 1987;35:27-30.","journal-title":"J Am Geriatric Soc"},{"key":"e_1_3_1_36_2","first-page":"2","volume":"43","year":"1993","unstructured":"Morris JC, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease. Neurology 1993;43:2457-2465.","journal-title":"Neurology"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.47.2.444","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T10:20:39Z","timestamp":1711534839000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.47.2.444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,8]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1996,8]]}},"alternative-id":["10.1212\/WNL.47.2.444"],"URL":"https:\/\/doi.org\/10.1212\/wnl.47.2.444","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,8]]}}}